Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968630 · ClinicalTrials.gov registry record · Phase 2
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
A Phase 2 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00968630: Completed Phase 2 study, sponsored by Fred Hutchinson Cancer Center.
NCT00968630 is a Phase 2 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00968630, a Phase 2 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This phase II trial studies the immune response after stem cell transplant in human immunodeficiency virus (HIV)-positive patients with hematologic cancer (blood cancer). Studying samples of blood from HIV-positive patients with cancer in the laboratory may help doctors learn more about changes that occur in the immune system after stem cell transplant.
Primary Outcome
HIV-1 specific immune responses will be evaluated in samples collected before and after HCT. These results will be used descriptively.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Leukapheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-12-17 |
| Est. Completion | 2017-03-17 |
| Phase | Phase 2 |
What the finished NCT00968630 record still lists
NCT00968630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00968630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00968630 about?
NCT00968630 is a clinical study titled "Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer". This phase II trial studies the immune response after stem cell transplant in human immunodeficiency virus (HIV)-positive patients with hematologic cancer (blood cancer). Studying samples of blood from HIV-positive patients with cancer in the laboratory may help doctors learn more about changes that...
What is the current status of trial NCT00968630?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2009-12-17. Estimated completion is 2017-03-17.
What interventions are being tested in trial NCT00968630?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Leukapheresis (PROCEDURE).
Who is sponsoring clinical trial NCT00968630?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00968630's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI